Somatoform disorders have rarely been addressed in epidemiological and health care services studies of the elderly. The few existing studies vary considerably in their methodologies limiting comparability of findings. Data come from the MentDis_ICF65+ study, in which a total of 3142 community-dwelling respondents aged 65-84 years from six different countries were assessed by the Composite International Diagnostic Interview adapted to the needs of the elderly (CIDI65+). The 12-month prevalence rate for any somatoform disorders was found to be 3.8, whereby the prevalence for somatization disorder according to DSM-IV was 0%, the prevalence for abridged somatization was 1.7% and the rate for 12-months somatoform pain disorder was 2.6%. We found a significant variation by study centre (p < 0.005). There was a significant gender difference for pain disorder, but not for abridged somatization. Significant age-related effects revealed for both disorder groups. Somatoform disorders were found to be associated with other mental disorders [odds ratio (OR) anxiety =4.8, OR affective disorders 3.6], as well as with several impairments and disabilities. Somatoform disorders are prevalent, highly impairing conditions in older adults, which are often associated with other mental disorders and should receive more research and clinical attention.
similar conclusion: more systematic research with special focus on the older population is needed, as current data are not sufficient to reveal the clinical relevance and natural course of somatoform disorders in the elderly. One important reason for the limited empirical data might be a general conceptual confusion accompanying the phenomenon of somatization, as one core disorder of the somatoform group. Diagnostic criteria for somatization disorder according to the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders [DSM-IV, American Psychiatric Association (APA, 1994) ] have frequently been criticized for being too restrictive. This criticism primarily concerns the precisely defined number and nature of symptoms as well as the need to judge a symptom as medically explained or not. It is not much surprising, that in the few epidemiological studies which assessed somatoform disorders in the elderly, prevalence rates are found to be marginal for somatization disorder with rates varying between 0.0% and 1.0% (Bland, Newman, & Thorn, 1988; Hessel, Geyer, Gunzelmann, Schumacher, & Brähler, 2003; Regier et al., 1988) and that they increase when less restrictive criteria are applied.
For instance Leikens, Finset, Monum, and Sandanger (2007) report six-month prevalence rates for "multisomatoform disorder" (at least three clinical relevant medically unexplained symptoms) of 9.8%, as well as somatoform disorder not otherwise specified (at least one clinical relevant medically unexplained symptom) of 13.5% in the elderly Norwegian population assessed by the Composite International Diagnostic Interview (CIDI). Hardy (1995) found a 12-month prevalence of 13% for at least one "somatoform symptom" for participants aged over 65 in a French community sample assessed by a semi-structured telephone interview. Those findings indicate that a large group of a subsyndromal form of somatoform disorders might exist in the elderly.
A common way to identify a clinical significant somatoform syndrome is by the use of the Somatic Symptom Index (SSI) introduced by Escobar, Burnam, Karno, Forsythe, and Golding (1987) . To fulfil criteria for the SSI or abridged somatization disorder at least four unexplained somatic complaints need to be present in men and six in women. The SSI has been validated in a number of studies and can be considered as a valuable operationalization of somatization for research purposes (De Gucht & Fischler, 2002; Escobar et al., 2010; Hiller, Rief, & Fichter, 1995 Kirmayer & Robbins, 1996; Mak & Zane, 2004; Portegijs et al., 1996; Rief et al., 1996) . This is also reflected by the widespread use of the SSI in a number of primary care studies (Gureje, Simon, Ustun, & Goldberg, 1997; Kirmayer & Robbins, 1991; Lobo, Garcia-Campayo, Campos, Marcos, & Perez-Echeverria, 1996) , as well as several large epidemiological studies (Jacobi et al., 2004; Ritsner, Ponizovsky, Kurs, & Modai, 2000; Robins et al., 1984; Wittchen, Nelson, & Lachner, 1998) .
As known from studies with younger individuals, somatoform disorders frequently co-occur with other mental disorders and often go along with significant impairments for example in quality of life or activities and participation Ladwig, Marten-Mittag, Erazo, & Gündel, 2001; Ritsner et al., 2000; Spitzer et al., 1995) . This might also be true for the elderly, as corresponding results could have been shown in several studies. Regarding comorbid mental disorders, somatoform disorders appear to be related to anxiety in the elderly (Rubio & Lopez-Ibor, 2007 ; Sheikh, Swales, King, Sazima, & Bail, 1999) as well as depressive disorders. Hilderink et al. (2009) found a current comorbid depressive disorder for 56% of their sample of elderly patients suffering from "medically unexplained symptoms". Depression was also found to be significantly associated with "medically unexplained somatic symptoms" in an elderly population-based Chinese sample, after adjusting for the effects of socio-demographic and medical characteristics (Yu & Lee, 2012) . With regard to impairment Cheng (1992) found a significant negative correlation between somatization and activities of daily living, and positive ones with experienced stress, chronic illness and loneliness-distress in a communitybased sample of elderly women.
| AIMS OF THE STUDY
Up to now empirical data on the prevalence of somatoform disorders in the elderly are rare and therefore valid estimations of the size and burden of this mental health problem are lacking. As most of the limited knowledge about somatoform disorders in the elderly comes from clinical settings, generalizability of results to the general population remains questionable. In fact the validity of results is narrowed to older treatment-seeking samples, which can be considered to differ from community-based samples in several ways. Hence, the aim of the current study is to provide knowledge about the prevalence and manifestation of somatoform disorders, in an elderly population-based sample, including analysis of comorbidity patterns, as well as the relation to general physical and mental health status, disability and functional impairment. More specifically we examined the following research questions in a population based sample of 65 to 85-year-old participants from different European countries: 
| METHODS
Findings are based on the MentDis_ICF65+ study on "Prevalence, 1-year incidence and symptom severity of mental disorders in the elderly: Relationship to impairment, functioning (ICF) and service utilization" funded by the European Commission within the seventh framework programme. Aims, design, and methods have been described in greater detail elsewhere (Andreas et al., 2013) and are only briefly described here.
| Study design
The MentDis_ICF65+ study is a multicentre study which aims to first develop a reliable diagnostic assessment battery appropriate and valid in the elderly and second collect data on the prevalence, the incidence and on the natural course and prognosis of mental disorders in sufficiently powered representative samples of older people (65-84 years) living in the community across different countries of the European Union (Spain, Italy, UK, Germany) and associated states (Switzerland, Israel) . This study is designed as a prospective epidemiological study.
For estimating the prevalence of mental disorders a cross-sectional study design was deployed.
| Sampling
In each of the six study centres approximately 500 respondents were selected to be interviewed within a defined catchment area. To achieve comparability of samples between the study centres and a similar power in all age and gender groups, two strata for age and gender were defined. Therefore over-sampling of the older age group, especially the older male, was implemented. Inclusion criteria for the participants were the ability to provide informed consent, living in the predefined catchment area and being between 65 and 84 years old. Exclusion criteria were severe cognitive impairment as assessed with the MMSE (Mini-Mental State Examination, cutoff score > 18) and insufficient level of language in which the interview was conducted. A random sample of the resulting cohort has been drawn according to the stratification criteria in each study centre from population registries or postal addresses from market research companies.
Participants were approached by a written invitation letter followed by a telephone call. Response rates varied between 11% and 33% across countries. Responder analyses showed no gender effect, but a significant age effect, indicating a higher response rate for younger participants (for more details see Volkert et al., under review and has been adapted to the particular social, cognitive and psychological abilities and needs of the elderly. The interview covers several mental health problems such as anxiety disorders, affective disorders and substance abuse. Somatic morbidity is assessed by asking participants for the existence of any medical condition (e.g. heart disease, cancer, and musculoskeletal disease). Moreover participants are asked to report their use of medication and contacts with the health care system. Preliminary evidence of satisfactory test-retest reliability and the feasibility of this extended and modified CIDI approach is provided by Wittchen et al. (2015) . Test-retest reliability was good for most core diagnostic categories however, agreement for the somatoform disorders was less satisfactory. The authors report limited specificity for the somatoform disorders, while sensitivity was found to be good. This can be explained by time lapse effects and the rather small sample size. Table A1 ). The traditional classification of abridged somatization disorder requires four symptoms in men and six in women out of the lengthy 46-item list (SSI4/6). As most gender-specific items were left out in the new somatoform symptom list, we decided to use the four symptom criterion for both sexes. To assess the psychometric property of the shortened list, we examined sensitivity and specificity on the basis of the German Health Survey (GHS, Jacobi et al., 2004) In line with the current DSM-IV criteria the assessment of the lifetime experience of somatoform symptoms is followed by identification and probing of clinically significant symptoms which cannot be entirely explained by a medical condition or substance use (alcohol, medication or drug). Clinical significance is indicated either by seeking help from a medical doctor or other mental health professional, or significant distress and interference with daily life because of the symptom. To examine whether a symptom is clinically unexplained the interviewer asks for the diagnosis the physician provided. Whenever the participant reports a medical condition or substance use the interviewer is directed to ask if the symptom in question has always been the result of a physical illness, injury or other somatic conditions respectively of taking medication, drugs or alcohol. These questions are also asked when a participant has not seen a physician due to the symptoms considered. Interviewers were instructed to rate diagnoses of functional somatic symptoms such as irritable bowel syndrome, fatigue, etc. as somatoform conditions rather than medical explanations to ensure that participants with such diagnoses were also evaluated in detail within the somatoform disorder section. Moreover the CIDI probes for the onset of each somatoform symptom, whereas age of last occurrence is only probed if the diagnostic threshold for the respective diagnosis is reached.
The CIDI65+ incorporates DSM-IV diagnostic algorithms for somatization disorder, abridged somatization disorder (SSI4) and pain disorder, while hypochondriasis and undifferentiated somatoform disorder are not included.
| Assessment of quality of life and level of functioning
In addition to the CIDI65+ two self-rated questionnaires to assess quality of life and functioning were deployed. The World Health Organization (WHO) Quality of Life BREF (WHOQoL-BREF, WHO, 2004 ) is a widely used instrument with good psychometric properties (WHOQoL Group, 1998) and can be successfully administered in older people (Naumann & Byrne, 2004) . In our study a shortened version of the original questionnaire was deployed, whereby satisfying correlation coefficients of r = 0.78-0.91 could be found between the reduced scale and the original scale in the pilot sample of the MentDis_ICF65+ study. The 12-item self-administered version of the WHO Disability Assessment Schedule II (WHODAS-II, WHO, 2000) was used to assess level of functioning in regard to cognition, mobility, self-care, getting along, life activities and participation. As part of the WHODAS it was also assessed how many days in the past month a respondent was totally unable to carry out his or her usual activities or work because of any health condition.
| Assessment of symptom severity
To rate symptom severity the Health of the Nation Outcome Scales 65+ (HoNOS65+, Burns et al., 1999) was used. This expert-rated instrument consists of 12 scales measuring severity in regard to behaviour, impairment, symptoms and social functioning. These scales are: behavioural disturbance, non-accidental self-injury, problem drinking or drug use, cognitive impairment, physical illness, hallucinations and delusions, depressive symptoms, other mental and behavioural symptoms (including somatoform symptoms), problems with relationships, Note: Percentages are weighted and take into account the clustered and stratified sample structure; Reference category = women.
problems with activities of daily living, problems with living conditions and problems with leisure activities. Each item is scored from zero (no problem) to four (severe problem) on a 5-point scale. A review of the psychometric properties of the HoNOS65+ concludes that the instrument has good validity, reliability, sensitivity to change, and utility (Pirkis et al., 2005) .
| Statistical analyses
All analyses were computed using Stata 12.1 (StataCorp, 2011). Analyses were weighted (regarding the number of inhabitants of countries, Eurostat, 2013) and take into account the clustered and stratified sample structure (study centre as cluster variable and four strata by sex and two age groups, 65-74 and older than 74 years). Two answer our first research question, the adjusted prevalence rates for all somatoform disorders were estimated as marginal means from a weighted logistic regression adjusting for age (in five-year intervals), gender and study centre.
We used logistic regressions adjusted for age, gender and study centre to explore the association between socio-demographic factors (marital status, financial situation, education) and somatoform disorders (present versus absent).
Logistic regression analyses were also performed to analyse the associations of somatoform and other mental and somatic disorders, Note: percentages are weighted and take into account the clustered and stratified sample structure. 
<0.01
Any substance-related disorder (n = 259) Note: Reported percentages are weighted and take into account the clustered and stratified sample structure; OR, odds ratio; CI, confidence interval; GAD < generalized anxiety disorder; OCD, obsessive compulsive disorder, PTSD, post-traumatic stress disorder.
4 | RESULTS
| Prevalence of somatoform symptoms and disorders
The frequencies of specific somatoform symptoms reported by participants in our sample are displayed in Table 1 . Overall 88.7% of respondents reported at least one somatoform symptom in their lifetime and 63.1% reported three or more symptoms. The three most frequently mentioned symptoms were back pain (60.1%), followed by pain in the joints (50.1%) and pain in arms or legs (36.1%). This rank order was similar for both sexes. We found several significant gender differences regarding the frequency of mentioned symptoms, whereby the most striking differences revealed for pain in the joints and headaches, which were reported more frequently by women, as well as for difficulties in urinating and sexual problems, which were reported more frequently by male participants (see Table 1 ). Table 2 ).
| Socio-demographic correlates
We found no significant gender differences in the prevalence rates for past-year abridged somatization disorder, but for pain disorder, whereby the odd to suffer from a past-year pain disorder was found to be higher for female participants [odds ratio (OR) = 1.87, 95%-CI [1.07;3.26]; p < 0.05; see Table 3 ]. Considering age-related differences, we found that the chance to suffer from past-year abridged somatiza- 
| Comorbidity
Individuals with a past-year somatoform disorder had a nearly four times higher chance to suffer from any past-year affective disorder higher chance to have a past-year anxiety disorder (OR =4.76, 6 .69]; p < 0.001) compared to participants without a somatoform disorder. We neither found a significant relation between any somatoform disorder and substance-related disorders (p = 0.095), nor with any 12-month physical illness (p = 0.157).
A more detailed analysis of comorbidity patterns showed that both, abridged somatization and pain were significantly associated with dysthymia and generalized anxiety disorder (GAD), as well as agoraphobia and post-traumatic stress disorder (PTSD). However, solely pain disorder was associated with major depression, specific and social phobia, whereby abridged somatization was associated with panic disorder and physical illness (see Table 4 ).
| Impairments and help-seeking behaviour
Analysing the associations between somatoform disorders and level of function adjusted for potential confounder variables (age, gender, anxiety disorders, affective disorders, PTSD, and physical illness)
revealed that both abridged somatization and pain disorder were significantly associated with increased values of overall functional impairment, significant decrease in health-related quality of life and an increase in expert-rated overall symptom severity. A significant increase in the number of disability days was only found for abridged somatization disorder. Moreover help-seeking behaviour, defined as the number of past year doctor visits, was increased for participants suffering from abridged somatization or pain disorder, whereby they reported nearly five more visits on average, compared to participants without abridged somatization or pain.
Furthermore the frequency of the use of analgesics within the past 30 days was higher for individual fulfilling criteria for abridged somatization or pain (see Table 5 ).
5 | DISCUSSION AND CONCLUSION
| Prevalence of somatoform symptoms and disorders
Overall 3.88% of elderly participants in this study met criteria for any past-year somatoform disorder. This rate is somewhat lower than those reported in other studies investigating somatoform disorders in younger age groups (Canino et al., 1987; Escobar et al., 1989; Hiller, Rief, & Braehler, 2006; Jacobi et al., 2004; Lieb, Pfister, Mastaler, & Wittchen, 2000; Ritsner et al., 2000; Robins et al., 1984 ) . However, the frequencies of reported single somatoform symptoms were higher in our sample, compared to a study by Rief, Hessel, and Braehler (2001) , who investigated somatization symptoms in the general population. This finding indicates that single somatoform symptoms might increase in older age groups, but do not lead to an increase in the prevalence of defined somatoform disorders.
We did not find one single case fulfilling criteria for somatization disorder according to DSM-IV, which is in line with other studies (Bland et al., 1988; Hessel et al., 2003; Regier et al., 1988) of abridged somatization disorder was found to be 1.67% in this study.
To our knowledge there is only one further study investigating abridged forms of somatization in the general elderly population (Leikens et al., 2007) . The authors of this study report a prevalence of 9.8% for at least three clinical relevant somatoform symptoms identified by the CIDI. This divergent finding might be due to the fact that in the study by Leikens et al. (2007) no age-specific version of the CIDI was used and that interviewers were not specially trained in interviewing older participants, as the study was a general population study covering all age groups with no special focus on elderly respondents; this might have led to an over-estimation of somatoform symptoms by misinterpretation of somatic symptoms as somatoform in their nature. In addition cultural differences could also be of importance in interpreting these findings, as we found significant variations between countries in the present study. However, cultural aspects of somatoform disorders are not the focus of the present study and should be investigated in more detail in future research. One preliminary explanation for the increased prevalence rates found in Israel, compared to the other study centres, might lie in the higher probability of experienced trauma and migration, which are both linked to somatization (Aragona et al., 2011; Bermejo, Nicolaus, Kriston, Hölzel, & Härter, 2012; Sack, Lahmann, Jaeger, & Henningsen, 2007; Waitzkin & Magana, 1997) .
| Correlates of somatoform disorders
In line with our expectations, we found a significant gender difference for pain disorder, with a higher chance to fall ill for female participants. However, unlike in studies of younger age groups, where women were found to be much more likely to suffer from any somatoform condition (Jacobi et al., 2004; Johnson, 2008; Kapfhammer, 2005; Ladwig et al., 2001; Tseng & Natelson, 2004 ),
we did not find a significant gender difference in the prevalence of abridged somatization. Yet, our finding is in line with the result by Hessel et al. (2003) , who found that elderly females did not report more somatoform symptoms than elderly males. The apparent disappearing of gender differences in older age groups might arise from the fact that traditional role perceptions become blurred, due to multiple symptoms and a general increasing dependency on others.
Another explanation might lie in the applied diagnostic criteria. As shown in previous studies the male/female ratio changes with defined symptom thresholds in the way that female predominance becomes less obvious with lower thresholds (Kroenke, Spitzer, deGruy, & Swindle, 1998; Liu, Clark, & Eaton, 1997; Rief et al., 2001; Robins et al., 1984) . Moreover we found a significant decline in the prevalence rate with age for pain disorder, while an opposite effect could be found for abridged somatization, indicating a different course of the two disorders. Further differences between these two somatoform subgroups revealed in observed comorbidity patterns.
Solely pain disorder was associated with specific phobia, social phobia and major depression, whereby abridged somatization was associated with panic disorder and physical illness. Besides these variations, a more general comorbidity pattern could also be found, underlining that comorbidity is common among elderly subjects suffering from abridged somatization and pain disorder. We found a strong association between both disorders and anxiety (GAD, as well as agoraphobia and PTSD), which is well known from adult populationbased studies (for an overview see Creed & Barsky, 2004) . There is some evidence that this association remains stable in older age groups (Rubio & Lopez-Ibor, 2007) , or even increases (Sheikh et al., 1999) , which is consistent with our findings. The association between somatoform and affective disorders was also found to be significant in our study, which is in line with previous results (Hilderink et al., 2009; Yu & Lee, 2012) . We initially focussed on examining comorbidity as independent from each other; however, it could be of interest in further research to explore the interplay between somatization, anxiety and chronic depression in more detail.
Another question of particular interest when considering comorbidity in an elderly population, concerns the relation between general medical conditions and somatoform symptoms. In our sample we found a strong association between abridged somatization and physical illness, in that participants suffering from abridged somatization had a 50-times higher chance to report a comorbid physical illness, indicating that almost all participants fulfilling criteria for past-year 
| Impairments and help-seeking
As shown in previous studies concerning younger age groups, somatoform disorders are associated with a wide range of impairments (e.g. Escobar et al., 1989; Gureje et al., 1997; Ladwig et al., 2001; Ritsner et al., 2000; Spitzer et al., 1995) . The burden which elderly people with a somatoform condition experience is underlined by the findings that reported functional impairment is higher for those suffering from abridged somatization or pain compared to other respondents.
Controlling for age, gender, comorbid anxiety and mood disorders in the analysis allows the interpretation of this finding as a correlate of somatization and pain itself, rather than an epiphenomenon of comorbid conditions. This finding is also in line by those from Cheng (1992) , who found a significant negative correlation between somatization and activities of daily living in a community-based sample of elderly women. Significantly increased rates of expert-rated overall symptom severity, as well as decreased rates of quality of life illustrate the considerable evidence for marked impairments of somatoform conditions in the elderly. Again those findings remain significant when controlling for age, gender and comorbid mental disorders and demonstrate the clinical importance of abridged somatization and pain disorder in the elderly.
Beside the earlier mentioned impairments, we found that participants suffering from abridged somatization or pain disorder reported an increased number of health care use and use of analgesics compared to respondents without any somatoform disorder. Unfortunately we did not have the chance to assess medication use in detail in our study and are currently unable to provide information about drug abuse or patterns of prescribed and non-prescribed use. Therefore the phenomenon of self-medication in elderly patients suffering from a somatoform disorder should be investigated in more detail in further studies.
| Limitations
To our knowledge, this is the first study which systematically assessed somatoform symptoms and disorders in a large community-based sample of older adults. However, some major limitations have to be considered when interpreting our results. As mentioned earlier satisfying reliability of the CIDI65+ somatoform disorder section could not have
been demonstrated yet partly due to time lapse effects and particularly low base rates of somatoform disorders within the test-retest study (Wittchen et al., 2015) , which clearly extenuates the interpretation of our results. Moreover the CIDI65+ does not cover the full spectrum of somatoform disorders, which is why we cannot provide any information about hypochondriasis or undifferentiated somatoform disorders in the elderly. Unfortunately we were not able to include new DSM-5 criteria (APA, 2013) in our study and therefore cannot make any statements about validity of this approach. However, our findings might support the decision to skip the restrictive criteria for somatization disorder to some extent, as we did not find a single case fulfilling them in our study.
In addition the rather low response rates might constrict external validity of our findings. Likewise a potential selection bias has to be kept in mind when interpreting the results of the present study. However, to assess the comparability of the recruited samples with the general population, comparisons with regard to socio-demographic characteristics were made between the MentDis sample and general population characteristics with satisfying results (Volkert et al., under review) .
Despite the limitations (s.a.) this study is valuable in demonstrating, in a large international community sample of older adults, that somatoform syndromes in the elderly are a prevalent, highly comorbid phenomenon, which accompanies significant impairment in functioning, quality of life and well-being. Compared to studies investigating somatoform conditions in younger age groups, the results of the present study suggest that prevalence rates decline after the age of 65, which is in line with the conclusions by Hilderink et al. (2013) , who discuss several potential explanations for a decrease in the prevalence of somatoform disorders in the elderly in a recent review. By using a standardized interview, which has been adapted to the needs of the elderly, and by inclusion of an abridged form of somatization we were able to address their main points of critique on previous research in the present study and provide a preliminary data base for further research and practice.
